STOCK TITAN

Paragon 28 Launches the Mister Tendon™ Harvester System – The First and Only Minimally Invasive Harvesting System for FHL and FDL Tendon Transfer Procedures

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
Paragon 28, Inc. (NYSE: FNA) has announced the launch of the Mister Tendon™ System, designed to allow surgeons to perform a distal cut of the flexor hallucis longus or flexor digitorum longus tendon through a minimally invasive incision. The system aims to improve healing and recovery time in flatfoot reconstruction. The press release also features comments from the CEO and surgeon designer, highlighting the company's commitment to addressing unmet needs of foot and ankle surgeons.
Positive
  • None.
Negative
  • None.

The introduction of the Mister Tendon™ System by Paragon 28 represents a significant advancement in the realm of foot and ankle surgery, particularly for tendon transfer procedures in flatfoot reconstruction. The system's minimally invasive approach aligns with the current trend towards reducing patient trauma and facilitating faster recovery times. This is crucial because the traditional open dissection method can lead to prolonged healing due to the extensive soft tissue damage it may cause. The Mister Tendon™ System's design, which allows for distal cuts of the FHL or FDL tendons through smaller incisions, could potentially minimize the risk of complications and improve surgical outcomes.

From a surgical perspective, the added value of the accessory dilator instrument cannot be understated. It aids in blunt dissection, which is a technique used to separate tissue planes while minimizing harm to surrounding structures. This is particularly beneficial in preserving neurovascular bundles that are critical for foot function and sensation. By improving access for the harvester without additional damage, the system could indeed fulfill the unmet needs in the field as claimed by Paragon 28's CEO.

The launch of the Mister Tendon™ Harvester System could potentially have a positive impact on Paragon 28's market position within the orthopedic device sector. The company's strategy to develop less invasive instruments aligns with the broader industry's push towards minimally invasive medical technologies, which have been gaining traction due to their benefits in reducing hospital stays and enhancing patient recovery. This system could appeal to surgeons and healthcare facilities aiming to improve patient outcomes and reduce overall healthcare costs associated with complex surgeries.

Paragon 28's comprehensive portfolio of flatfoot solutions, now bolstered by the Mister Tendon™ System, positions the company as a one-stop-shop for foot and ankle surgical needs. This could potentially lead to increased adoption rates among foot and ankle surgeons, thus driving revenue growth for the company. It's important to monitor how this product is received in the market, as well as its contribution to the company's financial performance in subsequent quarters.

The healthcare industry is increasingly focusing on cost-effective solutions that do not compromise on the quality of care. The Mister Tendon™ Harvester System by Paragon 28 could have implications for the economic aspects of healthcare delivery in orthopedic surgery. By potentially reducing the duration of hospital stays and the need for extensive postoperative care, this system may contribute to lowering the economic burden on both healthcare systems and patients. Furthermore, quicker recovery times could translate into reduced time away from work for patients, thereby lessening the indirect costs associated with surgical procedures.

As the system gains traction, it could also influence the competitive landscape, prompting other companies to innovate and offer similar minimally invasive solutions. This competition could drive down costs and improve the quality of care, benefiting the healthcare system overall. However, the initial costs of adopting new technologies like the Mister Tendon™ System must be weighed against the long-term savings to ensure that they are indeed cost-effective.

ENGLEWOOD, Colo.--(BUSINESS WIRE)-- Paragon 28, Inc. (NYSE: FNA), is pleased to announce the launch of the Mister Tendon™ System which allows surgeons to perform a distal cut of the flexor hallucis longus (“FHL”) or flexor digitorum longus (“FDL”) tendon through a minimally invasive incision, harvesting a working length of tendon suitable for tendon transfer procedures. Use of this instrumentation through a minimally invasive approach, is designed to allow for better healing and quicker recovery time in flatfoot reconstruction. In addition to the harvester, an accessory dilator instrument is provided to help bluntly dissect soft tissue, improving harvester access without causing additional damage.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240126686745/en/

Figure 1: Paragon 28 Mister Tendon™ Harvester and Blunt Dissection Probe (Graphic: Business Wire)

Figure 1: Paragon 28 Mister Tendon™ Harvester and Blunt Dissection Probe (Graphic: Business Wire)

Paragon 28’s CEO, Albert DaCosta, commented, “We are thrilled to add the Mister Tendon™ Harvester to our comprehensive and novel offering of flatfoot solutions. We are committed to addressing the unmet needs of foot and ankle surgeons and the launch of a minimally invasive tendon harvester fulfills a promise we have made to our customers to develop less invasive instrumentation and implants for the most common procedures in the foot and ankle.”

Surgeon designer Thomas San Giovanni, MD, commented, “As surgical procedures change with a noted trend towards minimally invasive surgery, so must instrumentation to facilitate the task at hand. In the words of Miyamoto Musashi, the famous Japanese master samurai and philosopher, 'Do nothing that is of no use.' There would be no use to carry out the typical open dissection of the patient's soft tissue structures and neurovascular structures if tendons could be harvested of the same length desired by using well thought out innovative instrumentation that facilitates minimally invasive harvest technique. In doing so, the same goal would be achieved all while sparing the anatomical region from needless dissection, avoiding surgical disruption of the soft tissue structural anatomy and microvasculature...do nothing that is of no use. The Mister Tendon Harvester™ was created based on this principle.”

The Mister™ Tendon Harvester System bolsters Paragon 28’s flatfoot solutions offering which includes the PRESERVE™ Cotton, Evans, and STJDA Wedges, Titan 3-D™ Cotton and Evans Wedges, Grappler™ Interference Screw System, Grappler™ Suture Anchor System, Gorilla® Calc Slide Plate, Gorilla® BOW & ARROW Plates, Gorilla® HEvans™ Plate, Gorilla® NC Fusion Plating System, Gorilla® Medial Column Plating System, Gorilla® Universal Plating System, JAWS Great White™ Staple System, and Monster® Hindfoot Screw System. With this comprehensive portfolio, Paragon 28® provides its customers with a single source to address their flatfoot needs.

About Paragon 28, Inc.

Based in Englewood, CO., Paragon 28, is a leading medical device company exclusively focused on the foot and ankle orthopedic market and is dedicated to improving patient lives. From the onset, Paragon 28® has provided innovative orthopedic solutions, procedural approaches and instrumentation that cover a wide range of foot and ankle ailments including fracture fixation, forefoot, ankle, progressive collapsing foot deformity (PCFD) or flatfoot, Charcot foot and orthobiologics. The company designs products with both the patient and surgeon in mind, with the goal of improving outcomes, reducing ailment recurrence and complication rates, and making the procedures simpler, consistent, and reproducible.

Forward Looking Statements

Except for the historical information contained herein, the matters set forth in this press release are forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, including, but not limited to: Paragon 28’s potential to shape a better future for foot and ankle patients. You are cautioned not to place undue reliance on these forward-looking statements. Forward-looking statements are only predictions based on our current expectations, estimates, and assumptions, valid only as of the date they are made, and subject to risks and uncertainties, some of which we are not currently aware. Forward‐looking statements should not be read as a guarantee of future performance or results and may not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. These forward‐looking statements are based on Paragon 28’s current expectations and inherently involve significant risks and uncertainties. Actual results and the timing of events could differ materially from those anticipated in such forward‐looking statements as a result of these risks and uncertainties. For a further description of the risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to Paragon 28’s business in general, see Paragon 28’s current and future reports filed with the Securities and Exchange Commission, including its Annual Report on Form 10-K for the fiscal year ended December 31, 2022 and its Quarterly Reports on Form 10-Q, as updated periodically with its other filings with the SEC. These forward-looking statements are made as of the date of this press release, and Paragon 28 assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements, except as required by law.

Disclaimer

Dr. San Giovanni may report consulting and royalty fees from Paragon 28 in connection with the provision of product development services to Paragon 28.

Nothing in this material is intended to provide specific medical advice or to take the place of written law or regulations.

Investor Contact

Matthew Brinckman

Senior Vice President, Strategy and Investor Relations

Phone: (720) 912-1332

mbrinckman@paragon28.com

Source: Paragon 28, Inc.

The ticker symbol for Paragon 28, Inc. is FNA.

The Mister Tendon™ System is designed to allow surgeons to perform a distal cut of the flexor hallucis longus or flexor digitorum longus tendon through a minimally invasive incision.

Paragon 28’s CEO, Albert DaCosta, and surgeon designer Thomas San Giovanni, MD, commented on the launch of the Mister Tendon™ Harvester.

Other products in Paragon 28’s flatfoot solutions offering include the PRESERVE™ Cotton, Evans, and STJDA Wedges, Titan 3-D™ Cotton and Evans Wedges, Grappler™ Interference Screw System, Grappler™ Suture Anchor System, Gorilla® Calc Slide Plate, Gorilla® BOW & ARROW Plates, Gorilla® HEvans™ Plate, Gorilla® NC Fusion Plating System, Gorilla® Medial Column Plating System, Gorilla® Universal Plating System, JAWS Great White™ Staple System, and Monster® Hindfoot Screw System.
Paragon 28 Inc

NYSE:FNA

FNA Rankings

FNA Latest News

FNA Stock Data

Surgical and Medical Instrument Manufacturing
Manufacturing
Link
US
Englewood

About FNA

paragon 28 was established in 2010 as an orthopedic foot and ankle company. the name “paragon 28” was chosen to show that we are exclusively a foot and ankle company, with the “28” representing the number of bones in the foot. we will remain true to that vision. paragon 28 was started as a small, family-based company and we have kept those core ideals as we have grown. our mission is to strategically build a company around the core principles that drive innovation and quality. relentlessly working to advance the science behind foot and ankle surgery, paragon 28 is passionate about and committed to: - creation and innovation: blending different surgical philosophies from various global thought leaders to develop bio-mechanically and clinically relevant surgical solutions. - a focus on service: a customer service based, dedicated, and highly trained distribution network to the foot and ankle market. - efficient practices: meeting the needs of increasing pricing pressures and reimbursemen